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Abstract
Background: Since antiretroviral therapy (ART) became available in the developed world, the prevalence of unprotected sex
and the incidence of sexually transmitted infections (STIs) and HIV have increased. We hypothesized that a similar
phenomenon may be occurring in sub-Saharan Africa concomitant with the scale-up of HIV treatment.
Methods: We conducted a general population-based survey in Kisumu, Kenya. Participants completed an interview that
included demographics as well as ART-related attitudes and beliefs (AB) and then underwent HIV serological testing.
Exploratory and confirmatory factor analyses of AB about ART indicated two factors: 1) ART-related risk compensation
(increased sexual risk taking now that ART is available); and 2) a perception that HIV is more controllable now that ART is
available. Logistic regression was used to determine associations of these factors with HIV-seroprevalence after controlling
for age.
Findings: 1,655 (90%) of 1,844 people aged 15–49 contacted, including 749 men and 906 women, consented to participate
in the study. Most participants (n = 1164; 71%) had heard of ART. Of those who had heard of ART, 23% believed ART was a
cure for HIV. ART-related risk compensation (Adjusted (A)OR= 1.45, 95% CI 1.16–1.81), and a belief that ART cures HIV
(AOR= 2.14, 95% CI 1.22–3.76) were associated with an increased HIV seroprevalence in men but not women after
controlling for age. In particular, ART-related risk compensation was associated with an increased HIV-seroprevalence in
young (aged 15–24 years) men (OR= 1.56; 95% CI 1.12–2.19).
Conclusions: ART-related risk compensation and a belief that ART cures HIV were associated with an increased HIV
seroprevalence among men but not women. HIV prevention programs in sub-Saharan Africa that target the general
population should include educational messages about ART and address the changing beliefs about HIV in the era of
greater ART availability.
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Introduction
In 2007, almost two-thirds of all HIV-positive persons were living
in sub-Saharan Africa, and an estimated 1.7 million adults and
children became infected that same year, more than in all the other
regions in the world combined [1]. Kenya has an advanced HIV
epidemic with an estimated 1.2 million persons, roughly 6.1% of the
total population, living with HIV [1]. Since the Declaration of
Commitment issued by the United Nations General Assembly
Special Session on AIDS in 2001, access to anti-retroviral therapy
(ART) and HIV/AIDS care in developing countries has become a
global priority. The Global HIV Prevention Working Group, the
World Health Organization strategy, ‘‘Treating 3 million by 2005,’’
and other HIV treatment initiatives have recommended the
integration of HIV prevention and treatment services. However,
there is little research available to guide the design and delivery of
evidence-based prevention services in the era of ART [2,3].
In sub-Saharan Africa, ART coverage among those eligible
increased from 2% in 2003 to 17% at the end of 2005, and access
to ART continues to increase rapidly [4]. ART in the public sector
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in Kenya was first piloted in late 2003 at five sites. Of the
estimated 250,000 persons requiring ART in Kenya, the number
of persons receiving ART increased from 65,000 (26%) to
110,000 (44%) between the start of 2006 and 2007 (Dr. Lyndon
Marani, ART program officer, National AIDS and STD Control
Program, Kenya, personal communication). In Kisumu, the
location of this investigation, of the estimated 37,784 persons
eligible for ART 4,972 (13%) and 10,464 (28%), were receiving
ART by the start of 2006 and 2007, respectively (Dr. Steven
Onditi, Kisumu District Medical Officer of Health Kisumu,
personal communication).
An epidemiologic model of HIV/AIDS, calibrated to sub-
Saharan Africa, predicted that treatment-centered programs
would produce smaller benefits than prevention-centered pro-
grams, but that integrating programs of prevention and treatment
would have a synergistic effect and yield optimal reductions in
HIV incidence and mortality [5]. Enhanced availability of HIV
treatment programs will likely facilitate HIV prevention by
reducing stigma, increasing HIV testing rates, and creating a
common infrastructure for HIV services [6]. At the same time, an
overemphasis on treatment programs could also detract from
prevention efforts and lead to reduced public concern about HIV
and increased HIV risk behaviors [7,8].
Numerous studies in the United States and Europe have
identified an upward trend in risky sexual behaviors since the
introduction of ART in 1996 [9]. More specifically, an association
has been identified between decreased concern about HIV due to
ART availability and unprotected sex [10,11,12,13,14]. Lending
further support to these findings, a longitudinal study of men who
have sex with men in the Netherlands observed that participants
who perceived HIV/AIDS as less threatening since ART
availability had a higher incidence of sexually transmitted
infections (STIs) and HIV [15].
Investigations of ART-related attitudes and beliefs (AB) in sub-
Saharan Africa are limited. A descriptive study of beliefs about
HIV/AIDS and ART among 105 HIV clinic patients in Soweto,
South Africa found that participants’ impressions of ART were
overly optimistic, for example that ART could cure HIV (49%)
and that ART would not cause side effects (36%) [16]. Although
several studies have found that regular access to treatment facilities
may promote safer sex for those on ART [17,18], no study to date
in Africa has examined AB about ART in the general population
and the extent to which ART-related AB are associated with HIV-
seroprevalence. Therefore, we conducted a population-based
survey to determine if AB about ART are associated with HIV-
seroprevalence during the scale-up of HIV treatment in sub-
Saharan Africa. We specifically hypothesized that AB about ART
indicating decreased concern about HIV and increased sexual
risk-taking due to ART availability would be associated with an
increased risk of testing HIV-seropositive. In addition, we
reasoned that if the association between ART-related AB and
HIV-seroprevalence reflected an increased likelihood of sexual risk
taking, then this association would be strongest among adolescents
and young adults – a group more likely to have become sexually
active since the roll out of ART.
Methods
Study site
The study took place in the Municipality of Kisumu, situated in
western Kenya on Lake Victoria. Kisumu is Kenya’s third largest
city with a population of approximately 400,000. The majority of
Kisumu’s residents belong to the Luo ethnic group, one of the
largest tribes in Kenya.
Study design
The first phase of the study consisted of rapid community
assessment with social mobilization of community leaders to
gather their input and support for the study. Focus group
discussions with community members were conducted to assess
local understanding of ART for development of our study
instrument. The acceptability of blood, urine and vaginal swabs
for specimen collection was also assessed, and standardized
methods of collection were developed. Finally, data collection
instruments were modified and pre-tested. The questionnaires
were written in English and then translated into the other
commonly spoken languages in Kisumu: Kiswahili and Dholuo.
The final study protocol, consent and questionnaire were
approved by the ethical committees of the Kenya Medical
Research Institute and the University of California, San Francisco.
Data collection took place from July–October 2006. Sampling
methods from the Four African Cities Study conducted in Kisumu
in 1997 were adopted and replicated as much as possible so that
sexual behavioral and STI/HIV data from the two studies would
be comparable [19].
Survey of the general population
Households were selected by two-stage sampling, and all
persons aged 15–49 years who slept in the house the night before
the first visit by the research team were eligible for the study.
Within Kisumu, 23 sentinel clusters were used that were
determined to be representative of the population in this
municipality. Sentinel clusters were supplemented with the
systematic selection of an additional 17 census enumeration areas
within the municipality of Kisumu, resulting in a total of 40
clusters for study. The Municipality of Kisumu includes both the
city center as well as surrounding rural areas. Of our 40 clusters,
22 were considered urban and 18 rural. All households in these
clusters were enumerated, and the total number of households in
our sampling frame was determined by the target sample size
(2000) adjusted for a 20% non-response rate divided by the
average number of eligible participants (2.15) per household.
Households were selected by systematic random sampling: a
random ‘start point’ was chosen between 1 and 4, with every
fourth household sampled thereafter.
Each household was visited a day or two prior to the study by
the community mobilizer, who informed selected households
about the study team’s upcoming visit. The household was then
visited by the study team. If eligible participants were not at home,
the study team made at least 2 additional visits to the household. If
no one was found at home on all three visits, this household was
replaced with the next household number. As shown in Figure S1,
of the 1,210 households in the original sampling frame, 708 were
contacted (59%) and 645 (53%) had at least one household
member who participated in the study. Of the 502 households that
needed replacement, 219 households (43%) participated in a
second round of sampling. This resulted in a total of 864
participating households. Of the 3,376 eligible persons in these
households, 1,844 (55%) were contacted and asked to enroll and
1532 (45%) were not at home during the study visit. Of the 1,844
who were contacted, 1655 (91%) people (749 men and 906 women
aged 15–49) enrolled in the study and 189 (9%) refused to enroll.
After giving written informed consent, each participant was
interviewed on sociodemographic characteristics, HIV knowledge,
ART-related AB, sexual history with spousal and non-spousal
partners, history of STIs, HIV testing history, and HIV risk
perception. The interviewer recorded participant responses in a
pre-programmed questionnaire in the personalized digital assistant
(PDA). Study interviews and specimen collections were carried out
ART Beliefs & HIV Risk
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at a private location in or nearby the homes of the study
participants. After the interview, study team members requested
that participants provide a peripheral venous blood sample. In
total, 1508 participants (91%) provided a blood sample (Figure
S1), which was tested for HIV. Study participants with symptoms
and/or signs suggestive of a STI were treated immediately by the
study nurse using the Kenyan guidelines for STI syndromic
management. HIV testing results were linked to interview data
using a separate ‘‘link’’ identification number to protect confiden-
tiality. Beginning approximately one to two weeks after specimen
collection, trained testing counselors offered HIV counseling and
test results both within the selected clusters and at a central
location in town. Those who tested HIV-positive were referred to
HIV care and treatment facilities.
Survey measures
Data were collected on background variables including: age,
gender, education, employment, religion, marital status, place of
birth, socioeconomic status, recent travel, and history of drug or
alcohol use. The section on HIV and ART-related AB was
adapted from prior studies and modified to fit the local context
[10,15,20]. The 13-item section regarding ART-related AB
assessed whether the participant was less concerned about HIV/
AIDS or reported that there was less need for safer sex since the
availability of ART. Possible responses included: ‘‘agree’’,
‘‘unsure’’, or ‘‘disagree.’’ If a participant did not have an answer
to a particular question the response was left blank. The
questionnaire underwent pre-testing with community members,
who were encouraged to give their perceptions regarding the
meaning of each question and voice concerns about any areas of
confusion. Informed by this process, the questionnaire was refined
to ensure that it was culturally appropriate, easy to understand,
and properly adapted from English into the two local languages.
Laboratory procedures
Laboratory HIV testing of venous blood was performed
according to Kenyan National guidelines for voluntary counseling
and testing. Specimens were first tested using parallel rapid assays
(Rapid Uni-GoldTM, Trinity Biotech, Ireland; and DetermineTM,
Inverness Medical Innovations, Delaware, USA). The presence of
two positive rapid assays was defined as HIV seropositive, and two
negative rapid assays was defined as HIV seronegative. Discordant
or indeterminate rapid assay results were resolved using HIV
ELISA (Vironostika HIV Uni-Form II Ag/Ab).
Data analysis
We began with an exploratory factor analysis (EFA) in order to
determine the structure of the 13 items that assessed ART-related
attitudes and beliefs. EFA allows for the estimation of the shared
variance in items that is explained by a given factor while
partialing out the influence of measurement error. The ability to
examine only the shared variance in items is the primary
advantage of EFA when compared to principal components
analysis, which examines all the variance in items (including
measurement error) [21]. Because the 13 items allowed for three
response options (agree = 2, unsure = 1, or disagree = 0) the EFA
was conducted using MPlus version 5.1 (Muthe´n & Muthe´n, Los
Angeles, CA), which allows one to conduct an EFA with
categorical indicators using the weighted least squares-mean and
variance-adjusted estimator [22]. Furthermore, since knowledge of
ART was a prerequisite to respond to these questions, we only
used data from the 71% of participants that responded that they
had heard of ART in the EFA. We interpreted the results of this
EFA by examining the number of eignvalues that were greater
than 1.50 as well as the degree to which items loaded strongly
(0.40 or higher) on a single factor with promax rotation. Next, we
conducted a confirmatory factor analysis (CFA) to examine if
specifying the factor structure from the EFA (where items only
loaded on one factor) was an adequate fit for the data. For the
present investigation, we utilized multiple indices of model fit: a
chi-square to degrees of freedom ratio (x2/df) less than three,
comparative fit index (CFI) values greater than 0.95, root mean
square error of approximation (RMSEA) values less than 0.06, and
weighted root-mean-square residual (WRMR) values less than
0.90 [23,24]. Informed by the results of the EFA and CFA, we
created composite scores for the factors. The associations of these
composite scores with HIV-seroprevalence were examined using
logistic regression in SPSS 15.0 (SPSS Inc., Chicago, Illinois,
USA). Given the cultural context of sub-Saharan Africa where
men are generally afforded greater autonomy and independence
than women, we theorized that the associations of ART-related
attitudes and beliefs with HIV-seroprevalence may vary as a
function of gender [25]. Consequently, separate logistic regression
analyses were conducted for men and women with age as a
covariate. Individuals who had prior knowledge of their HIV
serostatus were not included in these analyses. In order to facilitate
the interpretation of the adjusted odds ratio (AOR), the composite
scores for factors of ART-related attitudes and beliefs were
transformed into z-scores (M=0, SD=61). Where significant
associations between ART-related attitudes and beliefs with HIV-
seroprevalence were observed within a given gender, we
conducted follow-up logistic regression analyses to examine
whether this effect varied by age category (i.e., 15–24, 25–29,
30–39 and 40–49 years).
Sociodemographic characteristics were compared by HIV-
serostatus after stratification by gender, and controlling for age
by category (as above) using logistic regression; odds ratios (OR)
and 95% confidence intervals (CI) were calculated.
Results
Association of sociodemographic factors with HIV
seroprevalence
In general, sociodemographic findings were similar between the
1,508 participants who gave blood for HIV serological testing and
the 147 who refused testing (data not shown). Of those who
underwent HIV serological testing, 25% of participants were
between the ages of 15–19 years, 31% between 20–24 years, 17%
between 25–29 years, 18% between 30–39 years and 9% between
40–49 years. Most participants were Luo (77%) and Christian
(95%). The majority (53%) had only a primary school education,
36% had a secondary school education, 8% had college or
university education, and 3% had no formal education. Twenty
five percent of women and 16% of men who provided blood
samples were HIV seropositive (OR=1.7, 95% CI 1.3–2.8). HIV
seroprevalence increased significantly with age (Table 1). Among
those who tested HIV-seropositive, 9 of 109 (11%) men and 28 of
204 (14%) women reported prior knowledge of their positive HIV
serostatus. For men, being single was associated with a decreased
HIV seroprevalence, while for women being separated/divorced
or widowed was significantly associated with an increased HIV
seroprevalence in comparison to those who were married.
Women, but not men, with primary and secondary school
education had a higher HIV seroprevalence than those with
greater education. Employment had a protective effect for women
while for men employment was associated with a non-significant
increased HIV seroprevalence. Religious affiliation for men and
women and identified ethnicity for men were not associated with
ART Beliefs & HIV Risk
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Table 1. The association of sociodemographic factors and HIV2seroprevalence stratified by sex in Kisumu.
Variable Men Women
HIV2/ve HIV+/ve OR, 95% CI* HIV2/ve HIV+/ve OR, 95% CI*
Age category (years)
15–19 172 (96%) 7 (4%) 1.0 173 (90%) 19 (10%) 1.0
20–24 158 (87%) 24 (13%) 3.8 (1.8–8.3) 217 (80%) 54 (20%) 2.2 (1.2–4.0)
25–29 101 (78%) 29 (22%) 7.3 (3.4–15.5) 95 (70%) 40 (30%) 3.8 (1.9–7.6)
30–39 94 (80%) 24 (20%) 6.5 (2.7–15.6) 91 (59%) 63 (41%) 6.3 (3.4–11.6)
40–49 46 (65%) 25 (35%) 13.5 (5.5–33.4) 48 (63%) 28 (37%) 5.3 (2.7–10.5)
What is your marital status?
Married 146 (71%) 61 (30%) 1.0 275 (78%) 79 (22%) 1.0
Single 231 (93%) 18 (7%) 0.3 (0.1–0.6) 127 (86%) 21 (14%) 1.0 (0.5–2.0)
Separated/divorced 16 (76%) 5 (24%) 0.7 (0.2–2.1) 23 (61%) 15 (39%) 2.3 (1.2–4.3)
Widowed 2 (67%) 1 (33%) 0.8 (0.1–7.7) 14 (34%) 27 (66%) 4.4 (2.2–9.1)
Currently married?
No 249 (91%) 24 (9%) 1.0 164 (72%) 63 (28%) 1.0
Yes 146 (71%) 61 (29%) 2.6 (1.3–5.2) 275 (78%) 79 (22%) 0.5 (0.3–0.8)
Educational level
Primary 142 (77%) 43 (23%) 2.1 (0.8–5.3) 220 (72%) 85 (28%) 5.6 (1.8–17.6)
Secondary 189 (85%) 33 (15%) 1.6 (0.6–4.1) 166 (78%) 46 (22%) 3.7 (1.1–12.4)
College/University 63 (90%) 7 (10%) 1.0 43 (96%) 2 (4%) 1.0
Currently employed?
No 198 (89%) 25 (11%) 1.0 272 (76%) 85 (24%) 1.0
Yes 197 (77%) 60 (23%) 1.5 (0.9–2.6) 167 (75%) 57 (25%) 0.7 (0.5–0.97)
Religion
Catholic 122 (84%) 24 (16%) N/A 104 (72%) 41 (28%) N/A
Other Christian 248 (81%) 58 (19%) 319 (77%) 94 (23%)
Muslim 20 (87%) 3 (13%) 15 (88%) 2 (12%)
No religion 2 (100%) 0 (0%) 0 (0%) 3 (100%)
Other 3 (100%) 0 (0%) 1 (33%) 2 (67%)
Christian
No 25 (89%) 3 (11%) 1.0 16 (70%) 7 (30%) 1.0
Yes 370 (82%) 82 (18%) 1.6 (0.3–8.0) 423 (76%) 135 (24%) 0.8 (0.3–2.2)
Luo
No 81 (84%) 15 (16%) 1.0 108 (82%) 23 (18%) 1.0
Yes 314 (82%) 70 (18%) 1.4 (0.7–2.8) 331 (74%) 119 (26%) 2.0 (1.2–3.2)
Location
Rural 189 (80%) 48 (20%) 1.6 (0.9–2.8) 207 (74%) 72 (26%) 1.1 (0.7–1.6)
Urban 206 (85%) 37 (15%) 1.0 232 (77%) 70 (23%) 1.0
Had alcohol last four weeks?
No 235 (88%) 32 (12%) 1.0 395 (78%) 115 (22%) 1.0
Yes 160 (75%) 53 (25%) 1.9 (1.2–3.0) 44 (62%) 27 (38%) 2.1 (1.3–3.5)
Drug use ever?
No 236 (88%) 31 (12%) 1.0 397 (77%) 122 (23%) 1.0
Yes 159 (75%) 54 (25%) 2.2 (1.3–3.7) 42 (68%) 20 (32%) 1.5 (0.8–2.8)
Do you have electricity?
No 261 (80%) 66 (20%) 1.0 284 (72%) 113 (28%) 1.0
Yes 134 (88%) 19 (12%) 0.6 (0.3–0.7) 155 (84%) 29 (16%) 0.5 (0.3–0.7)
Of those who had prior HIV testing, HIV result at last testing?
Positive 3 (30%) 9 (70%) 13.5 (4.2–42.5) 1 (3%) 28 (97%) 176 (21–1504)
Negative 194 (89%) 23 (11%) 1.0 288 (87%) 44 (13%) 1.0
ART Beliefs & HIV Risk
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HIV. However, Luo women were two-times more likely to be HIV
infected than women of other ethnic groups. Alcohol use for men
and women and other drug use for men correlated with increased
HIV infection. Although we did not directly ask about income,
presence of electricity at one’s home was associated with a lower
HIV seroprevalence. As expected, a history of a positive HIV test
strongly correlated with HIV test results performed as part of the
study. Eleven percent of men and 11% of women who reported
testing HIV negative during their last HIV test seemingly
seroconverted. Women who reported that they did not return
for prior HIV test results had a higher HIV seroprevalence than
those who had never been tested (Table 1).
ART-related attitudes and beliefs
Of the 1,508 participants who were tested for HIV, most (71%)
had heard of ART, with no significant differences by sex (men:
71% vs. women: 71%, p= .53). Of those who had heard of ART,
87% thought that ART would be available to them if needed and
77% knew of a health facility where they could get ART. Nearly
all (98%) agreed that ART prolongs life, while 23% believed that
ART was a cure for HIV/AIDS and 26% thought that ART had
no side effects. Using the 13 items that assessed ART-related
attitudes and beliefs, we conducted an EFA and observed two
eignvalues that were greater than 1.50 (eignvalues = 2.50 and
4.67). This suggests that two factors most adequately summarize
these data. Of the 13 items, 11 loaded strongly ($0.40) on a single
factor in the EFA. Two items (‘‘ART cures HIV/AIDS’’ and
‘‘ART increases one’s sexual drive’’) did not load strongly (,0.40)
on either factor. As a result, these items were not included in the
CFA. For the CFA, we observed that the model was an adequate
fit for the data (x2/df = 2.92, CFI= .96, RMSEA=0.04,
WRMR=1.09). All four items for the first factor and all seven
items for the second factor loaded strongly ($0.40). As
summarized in Table 2, the 4-item factor appeared to reflect
perceptions that HIV/AIDS is more controllable since the
availability of ART (Cronbach’s a= .61), while the 7-item factor
seemed to measure ART-related risk compensation (Cronbach’s
a= .66). Because it was not easily summarized by either of the
factors, we included the belief that ‘‘ART cures HIV/AIDS’’ as a
single item predictor in subsequent analyses. We reasoned that this
fixed, incorrect belief may have important implications for sexual
risk taking behavior and HIV-seroprevalence.
Association of ART-related attitudes and beliefs with HIV-
seroprevalence
After controlling for age, ART-related risk compensation (Table 2)
was associated with increased HIV-seroprevalence for men
(AOR=1.45, 95% CI 1.16–1.81) but not for women
(AOR=1.08, 95% CI .89–1.31). The perception that HIV/AIDS
is more controllable since the availability of ART (Table 2) was not
statistically associated with HIV-seroprevalence for men
(AOR=1.28, 95% CI .97–1.69) or women (AOR= .99, 95% CI
.82–1.20) after controlling for age. These AORs reflect the increase
in the odds for testing HIV-positive that is associated with one
Variable Men Women
HIV2/ve HIV+/ve OR, 95% CI* HIV2/ve HIV+/ve OR, 95% CI*
Did not get results slip 4 (67%) 2 (33%) 5.0 (0.5–52.5) 18 (75%) 6 (25%) 3.2 (1.1–9.8)
Length of time in Kisumu?
,1 year 40 (83%) 8 (17%) 1.0 58 (88%) 8 (12%) 1.0
1 to 5 years 102 (87%) 15 (13%) 0.6 (0.2–1.8) 125 (82%) 28 (18%) 1.5 (0.6–3.4)
5+ years 253 (80%) 62 (20%) 0.9 (0.4–2.0) 256 (71%) 106 (29%) 1.9 (0.9–4.2)
*Adjusted for age category.
doi:10.1371/journal.pone.0004573.t001
Table 1. Cont.
Table 2. Factors derived from ART-related attitudes and beliefs.
Factor 1: Belief that HIV is a more controllable disease due to ART availability (a= .61)
Now that ART is available, HIV is less serious than it used to be.
Now that ART is available, it is more important for people to know their HIV status.
Now that ART is available, HIV/AIDS is a controllable disease.
Now that ART is available, people are more willing to get tested for HIV.
Factor 2: ART-related risk compensation (a= .66)
Now that ART is available, people do not need to be as concerned about becoming HIV-positive.
Now that ART is available, condom use during sex is less necessary.
Now that ART is available, you are less worried about HIV infection.
Now that ART is available, you are more likely to have more than one sexual partner.
Now that ART is available, you are more willing to take a chance of getting infected or infecting someone else with HIV.
Now that ART is available, someone who is HIV-positive does not need to worry as much about condom use.
Now that ART is available, you are more likely to have sex without a condom.
doi:10.1371/journal.pone.0004573.t002
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standard deviation increase in the specified factor. Finally, a belief
that ART cures HIV/AIDS was associated with increased HIV-
seroprevalence among men (AOR=2.14, 95% CI 1.22–3.76) but
not women (AOR=1.43, 95%CI .93–2.21) after controlling for age.
Because we hypothesized that the effect of any association
would be greatest for adolescents and young adults we performed
further analysis stratified by age categories for men. ART-related
risk compensation was associated with increased HIV-seropreva-
lence among 15–24 year old men. In addition, a belief that ART
cures HIV/AIDS was associated with a markedly elevated HIV-
seroprevalence among 25–29 year old men (Table 3). Results of
the age-controlled and age-stratified analyses were virtually
unchanged when the 7 men and 27 women who reported a
previous HIV-positive test and were confirmed HIV-positive in the
study were excluded (data not shown).
Changes in HIV-seroprevalence between 1997 and 2006
Because we replicated the sampling methodology used in the
Four African Cities Study performed in 1997, we were able to
assess changes in HIV-seroprevalence in the Kisumu population
between the two time periods. Nevertheless, the percentages of
eligible individuals who participated and gave a blood specimen
for HIV serological testing in sampled households were signifi-
cantly lower in 2006 than in 1997 for women (47% vs. 75%) and
for men (42% vs. 61%) (Table 4). Between 1997 and 2006, the
prevalence of HIV declined from 30% to 25% in women and 20%
to 17% in men [26]. HIV seroprevalence had the greatest decline
in women 15–29 years of age with a less pronounced decline in
men 25–39 years of age (Figure S2a & S2b) [19,26]. The HIV
seroprevalence was reduced by 57% in 15–19 year old women,
47% in 20–24 year old women and 19% in 25–29 year old
women. Among women aged 30–39 and 40–49 years, HIV
seroprevalence increased by 37% and 95%, respectively. Among
men, HIV seroprevalence was unchanged for 15–19 year olds,
with a 12% increase in 20–24 year olds and a 25% increase in 40–
49 year olds. For men 25–29 and 30–39 year old, HIV
seroprevalence reduced by 24% and 29%, respectively.
Discussion
To our knowledge, this is the first population-based study in the
developing world to examine the AB about ART and their
relationship with HIV seroprevalence. Previous studies in sub-
Saharan Africa have focused on the ART-related AB of HIV-
positive persons receiving HIV care. The data from this cross-
sectional study cannot provide evidence for a causal relationship,
but we are able to gain a general understanding of attitudes and
beliefs about ART in Kisumu, Kenya, where access to ART is
rapidly expanding, and the ways that these attitudes and beliefs
may increase risk for HIV infection.
Table 3. Odds ratios for the association between ART-related attitudes and beliefs, and HIV seroprevalence among men of
different age categories.
15–24 Years Old (n=233) 25–29 Years Old (n =99) 30–39 Years Old (n =90) 40–49 Year Old (n =58)
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
HIV is more controllable since ART
factor*
1.30 (0.79–2.17) 1.45 (0.87–2.41) 1.07 (0.59–1.94) 1.30 (0.69–2.43)
ART-related risk compensation factor* 1.56 (1.12–2.19) 1.35 (0.80–2.28) 1.45 (0.87–2.40) 1.32 (0.83–2.11)
‘‘ART Cures HIV/AIDS’’ 1.58 (0.54–4.60) 3.43 (1.17–10.08) 2.27 (0.72–7.16) 1.56 (0.43–5.58)
*See Table 2 for attitudes and beliefs included in each factor.
doi:10.1371/journal.pone.0004573.t003
Table 4. Comparison of individual response rates between 2006 and 1997 [19] by age categories for men and women in Kisumu,
Kenya.
Eligible Participants Interview (% Eligible) Blood Taken (% Eligible)
2006 1997 2006 1997 2006 1997
Men
15–19 years 401 239 197 (49%) 194 (81%) 179 (45%) 146 (61%)
20–29 years 729 376 350 (48%) 319 (85%) 312 (43%) 242 (64%)
30–39 years 339 259 128 (38%) 211 (81%) 118 (35%) 154 (59%)
40–49 years 158 140 74 (47%) 105 (75%) 71 (45%) 84 (60%)
All 1627 1014 749 (46%) 829 (82%) 680 (42%) 626 (62%)
Women
15–19 years 447 323 213 (48%) 281 (87%) 192 (43%) 226 (70%)
20–29 years 824 469 445 (54%) 427 (91%) 406 (49%) 368 (78%)
30–39 years 315 266 169 (54%) 234 (88%) 154 (49%) 196 (74%)
40–49 years 163 133 79 (49%) 118 (89%) 76 (47%) 103 (77%)
All 1749 1191 906 (52%) 1060 (89%) 828 (47%) 893 (75%)
doi:10.1371/journal.pone.0004573.t004
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In general, the majority of participants had heard of ART and
knew some basic information about it, but a sizeable minority had
misinformation (that ART is a cure). The majority of those who
had heard of ART thought that HIV was a less serious threat now
that ART is available. However, the most widely agreed upon
statement was that ‘‘knowing one’s HIV status is more important
now that ART is available.’’ This indicates that ART availability
could provide a strong impetus for HIV testing and potentially
encourage HIV prevention behaviors through awareness of HIV
status [6].
Young people represent not only one of the highest risk groups
for HIV acquisition and transmission, but also are the group most
likely to have become HIV-infected during the period in which
ART became available in Kisumu. In our study, young men who
reported ART-related AB consistent with risk compensation and
those who believed that ART was a cure for HIV/AIDS had a
significantly higher adjusted odds of being HIV positive than other
young men without these attitudes and beliefs. Why these findings
were limited to the male study population cannot fully be
explained by these data. However, several hypotheses may
account for the different results found between men and women.
In Kenyan culture, as in many cultures worldwide, men are more
able to act on their attitudes and beliefs than women especially in
regards to sexual activity [25]. Thus, for women the risk of
acquiring HIV may be more a marker of their sexual partner’s
attitudes and beliefs than of their own [27,28] and the indirect
effect of economic deprivation [29]. Additionally, the association
between ART-related beliefs and HIV may not represent a causal
association between beliefs and risk of HIV acquisition, but rather
a ‘‘risk-taking’’ personality that is characterized by indifference
toward risk and risky behaviors. In fact, we presume many of the
HIV infections discovered occurred prior to the roll-out of ART
services in Kisumu that started approximately three years before
onset of this study and before knowledge about ART was
widespread in the general population. It is also possible that there
are different perceptions of risk between the sexes [30,31], and
that a risk-taking subgroup of men were more likely to have HIV
and also more likely to be reassured that ART makes HIV less
threatening. Any of these reasons for the association between ART
AB and HIV prevalence could ultimately fuel the HIV epidemic;
men who knowingly or unknowingly are HIV-infected engaging in
higher risk sexual activity will ultimately lead to greater HIV
transmission.
Despite the fact that every effort was made to adopt sampling
procedures from the Four African Cities Study our response rates
for the present investigation were significantly lower [19, Table 4];
thus, comparisons must be made with some degree of caution.
Nevertheless, the declines in HIV seroprevalence, especially
among women, are heartening and may represent the effects of
greater awareness about HIV [32], reduction in STIs [33] and
change in sexual behavior [34]. The increased HIV seropreva-
lence in older women and men may represent a cohort effect (i.e.,
the higher prevalence in younger women in the 1997 survey are
now reflected in the cohort almost 10 years older), or could
alternatively demonstrate a worrying trend towards increased HIV
seroconversion in this age group. It is also noteworthy that the
reduction in HIV seroprevalence was less marked in men. This
may be the result of continued high risk exposure among men in
comparison to women, and/or the fact that the majority of
prevention efforts in Kisumu have focused on young women.
Alternatively, men were less likely to be at home and were more
challenging to recruit for this study; thus, men who enrolled may
represent a higher risk group than those we could not locate for
this study perhaps due to an illness, such as HIV that caused men
to stay at home. With male circumcision services becoming more
widely available in Kisumu, it is likely that the HIV seroprevalence
will decline further in men over the next decade [35,36,37].
Nevertheless, it is important to interpret the comparison of these
two HIV-seroprevalence estimates from 1997 and 2006 with some
caution. Although differences between the1997 to 2006 Kisumu
data may reflect true changes in HIV-seroprevalence, it is also
plausible that these differences are attributable to variability in
sampling procedures for these studies. We also suspect that growth
and urbanization of Kisumu has led to a decreased likelihood of
contacting eligible participants at home. Over and above these
limitations, improved care of people living with HIV and increased
availability of ART in Kisumu are likely important factors
contributing to recently observed declines in HIV-related
mortality [38]. Similarly, we can hope for a further decline in
new HIV infections as access to ART continues to increase
[39,40]. Findings from the present investigation underscore the
need for enhanced efforts to prevent HIV seroconversion in sub-
Saharan Africa, especially among young men and their sexual
partners who may be more vulnerable to contracting HIV due to
attitudes that reflect ART-related risk compensation or incorrect
beliefs that ART cures HIV/AIDS.
In the developed world, various study designs have been used to
investigate the impact of ART availability on risky sexual
behaviors. These studies have primarily examined the association
between ART-related AB and self-reported sexual behaviors. One
longitudinal study observed an association between ART-related
AB and incident STIs and HIV in men who have sex with men
[15]. Additionally, ecological data have demonstrated riskier
sexual behaviors and increased incidence of STIs and HIV among
men who have sex with men in San Francisco since the
introduction of ART in 1995 [41]. Our study addressed many
of the significant limitations to prior studies in the developed
world. Our sampling methodology was designed to be represen-
tative of the residents of the Kisumu Municipality. As a result, we
were able to examine the association of ART-related AB with
HIV-seroprevalence in the general population rather than
targeting specific high risk groups through methods that did not
employ random sampling.
Limitations of this study include the lower than expected
response rate, potential bias introduced by 9% of the study
population choosing not to provide blood for HIV-testing, and the
17% lower than expected sample size causing a small reduction in
power leading to our ability to only detect effects from 1.3 to 1.6
fold. We acknowledge that our sample population represents
individuals that could be eventually contacted at home and may
not represent everyone who lives in the community. The study
team often made greater than the required three visits to contact
all eligible household members, and we made visits to the
household during the evening and weekend in order to increase
enrollment as well as contact individuals not at home during
daytime hours (e.g. students and persons employed outside of the
home). Despite these efforts, there were many households with no
members at home, and due to logistical constraints, we were not
able to extend the study to further track household members or
sample additional households. Our response rates were lower than
the Four African Cities Study [26], perhaps due to differences in
recruitment efforts, but we also suspect the growth and
urbanization of Kisumu has led to a decreased likelihood of
contacting eligible participants at home.
Despite the possible limitations of this study, the results have
implications for community education and HIV prevention
interventions. The current model of HIV prevention and
treatment in Kisumu and much of the world is that HIV
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prevention programs work within the community, while care and
treatment programs provide both HIV treatment and prevention
counseling for those who are HIV-positive in medical clinics.
Voluntary counseling and testing is the primary referral source
that informs HIV-positive persons about the availability of HIV
care and treatment programs and the benefits of ART. Our data
suggest that there is need for more widespread dissemination of
accurate information about ART and for integration of ART-
related education with HIV risk-reduction counseling. HIV
prevention messages should address changing attitudes about
HIV and sexual risk-taking now that ART is becoming widely
available.
Supporting Information
Figure S1 Household and individual response rates
Found at: doi:10.1371/journal.pone.0004573.s001 (0.03 MB
DOC)
Figure S2 Comparison of HIV seroprevalence among women
and men in Kisumu, Kenya 1997 & 2006
Found at: doi:10.1371/journal.pone.0004573.s002 (0.03 MB
DOC)
Acknowledgments
Our success in completing this study was due to the tireless efforts of the
research team in the field especially field team leaders Solace Awuor
Amboga, Vitalis Akora, John Marie Mbeche and Juma G. Juma), the lab
Hannah Kimenyu and Albert Okumu), and the data (Edmund Njeru Njagi
and Hesbon Ooko) and administrative (Jacob Magige, Michael Mureithi
and Barrack Onyango) offices, as well as strong collaboration and support
from the community leaders and residents of Kisumu. The authors would
also like to thank the following for their generous support: The Director
KEMRI, the Director Centre for Microbiology Research; and the UNIM
Project for their hospitality. This work is published with the permission of
the Director KEMRI.
Author Contributions
Conceived and designed the experiments: CRC MM SS RB RN EB.
Performed the experiments: CRC MM AO ZK EB. Analyzed the data:
CRC MM AWC SS AB RB RN EB. Wrote the paper: CRC MM AWC
SS AB AO ZK RB RN EB.
References
1. AIDS Epidemic Update. World Health Organization Joint United Nations
Programme on HIV/AIDS (2007).
2. HIV Prevention in the Era of Expanded Treatment Access (2004) Global HIV
Prevention Working Group. Kaiser Family Foundation.
3. Emergency scale-up of antiretroviral therapy in resource-limited settings:
Technical and operational recommendations to achieve 3 by 5. Geneva: Joint
United Nations Programme on HIV/AIDS (2004) World Health Organization
Joint United Nations Programme on HIV/AIDS.
4. HIV Prevention in the Era of Expanded Treatment Access (2005) World Health
Organization Joint United Nations Programme on HIV/AIDS.
5. Salomon JA, Hogan DR, Stover J, Stanecki KA, Walker N, et al. (2005)
Integrating HIV prevention and treatment: from slogans to impact. PLoS Med
2: e16.
6. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, et al. (2000) Cost-
effectiveness of voluntary HIV-1 counselling and testing in reducing sexual
transmission of HIV-1 in Kenya and Tanzania. Lancet 356: 113–121.
7. Abbas UL, Anderson RM, Mellors JW (2006) Potential impact of antiretroviral
therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.
J Acquir Immune Defic Syndr 41: 632–641.
8. Creese A, Floyd K, Alban A, Guinness L (2002) Cost-effectiveness of HIV/AIDS
interventions in Africa: a systematic review of the evidence. Lancet 359:
1635–1643.
9. Gremy I, Beltzer N (2004) HIV risk and condom use in the adult heterosexual
population in France between 1992 and 2001: return to the starting point? Aids
18: 805–809.
10. Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, et al. (2002) Attitudes
towards highly active antiretroviral therapy are associated with sexual risk taking
among HIV-infected and uninfected homosexual men. Aids 16: 775–780.
11. van der Straten A, Gomez CA, Saul J, Quan J, Padian N (2000) Sexual risk
behaviors among heterosexual HIV serodiscordant couples in the era of post-
exposure prevention and viral suppressive therapy. Aids 14: F47–54.
12. Vanable PA, Ostrow DG, McKirnan DJ, Taywaditep KJ, Hope BA (2000)
Impact of combination therapies on HIV risk perceptions and sexual risk among
HIV-positive and HIV-negative gay and bisexual men. Health Psychol 19:
134–145.
13. Wilson TE, Gore ME, Greenblatt R, Cohen M, Minkoff H, et al. (2004)
Changes in sexual behavior among HIV-infected women after initiation of
HAART. Am J Public Health 94: 1141–1146.
14. Crepaz N, Hart TA, Marks G (2004) Highly active antiretroviral therapy and
sexual risk behavior: a meta-analytic review. Jama 292: 224–236.
15. van der Snoek EM, de Wit JB, Gotz HM, Mulder PG, Neumann MH, et al.
(2006) Incidence of sexually transmitted diseases and HIV infection in men who
have sex with men related to knowledge, perceived susceptibility, and perceived
severity of sexually transmitted diseases and HIV infection: Dutch MSM-Cohort
Study. Sex Transm Dis 33: 193–198.
16. Nachega JB, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, et al.
(2005) HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and
practices in HIV-infected adults in Soweto, South Africa. J Acquir Immune
Defic Syndr 38: 196–201.
17. Bateganya M, Colfax G, Shafer LA, Kityo C, Mugyenyi P, et al. (2005)
Antiretroviral therapy and sexual behavior: a comparative study between
antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and
research center in Kampala, Uganda. AIDS Patient Care STDS 19: 760–768.
18. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, et al. (2006)
Changes in sexual behavior and risk of HIV transmission after antiretroviral
therapy and prevention interventions in rural Uganda. Aids 20: 85–92.
19. Buve A, Carael M, Hayes RJ, Auvert B, Ferry B, et al. (2001) The multicentre
study on factors determining the differential spread of HIV in four African cities:
summary and conclusions. Aids 15 Suppl 4: S127–131.
20. Vanable PA, Ostrow DG, McKirnan DJ (2003) Viral load and HIV treatment
attitudes as correlates of sexual risk behavior among HIV-positive gay men.
J Psychosom Res 54: 263–269.
21. Tabachnick BG, Fidell SL (2001) Using Multivariate Statistics: Fourth Edition.
Needleham Heights, MA: Allyn & Bacon.
22. Muthe´n LK, Muthe´n B (2004) Mplus User’s Guide. Los Angeles, CA: Muthen
and Muthen, Inc.
23. Hu L, Bentler PM (1998) Fit indices in covariance structure modeling: Sensitivity
to underparameterized model misspecification. Psychol Methods. pp 424–453.
24. Kline RB (1998) Principles and Practice of Structural Equation Modeling. New
York: Guilford Press.
25. Shisana O, Davids A (2004) Correcting gender inequalities is central to
controlling HIV/AIDS. Bull World Health Organ 82: 812.
26. Buve A, Carael M, Hayes RJ, Auvert B, Ferry B, et al. (2001) Multicentre study
on factors determining differences in rate of spread of HIV in sub-Saharan
Africa: methods and prevalence of HIV infection. Aids 15 Suppl 4: S5–14.
27. Ferguson A, Pere M, Morris C, Ngugi E, Moses S (2004) Sexual patterning and
condom use among a group of HIV vulnerable men in Thika, Kenya. Sex
Transm Infect 80: 435–439.
28. Luke N (2005) Confronting the ‘sugar daddy’ stereotype: age and economic
asymmetries and risky sexual behavior in urban Kenya. Int Fam Plan Perspect
31: 6–14.
29. Dodoo FN, Zulu EM, Ezeh AC (2007) Urban-rural differences in the
socioeconomic deprivation–sexual behavior link in Kenya. Soc Sci Med 64:
1019–1031.
30. Blanc AK (2001) The effect of power in sexual relationships on sexual and
reproductive health: an examination of the evidence. Stud Fam Plann 32: 189–213.
31. Varga CA (2000) Young people, HIV/AIDS, and intervention: barriers and
gateways to behaviour change. Dev Bull. pp 67–70.
32. Wools KK, Menya D, Muli F, Heilman D, Jones R (1998) Perception of risk,
sexual behaviour and STD/HIV prevalence in western Kenya. East Afr Med J
75: 679–683.
33. Orroth KK, White RG, Korenromp EL, Bakker R, Changalucha J, et al. (2006)
Empirical observations underestimate the proportion of human immunodefi-
ciency virus infections attributable to sexually transmitted diseases in the
Mwanza and Rakai sexually transmitted disease treatment trials: Simulation
results. Sex Transm Dis 33: 536–544.
34. Hallett TB, Lewis JJ, Lopman BA, Nyamukapa CA, Mushati P, et al. (2007) Age
at first sex and HIV infection in rural Zimbabwe. Stud Fam Plann 38: 1–10.
35. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. (2007) Male
circumcision for HIV prevention in young men in Kisumu, Kenya: a
randomised controlled trial. Lancet 369: 643–656.
36. Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC (2007) Modelling the public
health impact of male circumcision for HIV prevention in high prevalence areas
in Africa. BMC Infect Dis 7: 16.
37. Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, et al. (2006)
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS
Med 3: e262.
ART Beliefs & HIV Risk
PLoS ONE | www.plosone.org 8 March 2009 | Volume 4 | Issue 3 | e4573
38. Mathers CD, Loncar D (2006) Projections of global mortality and burden of
disease from 2002 to 2030. PLoS Med 3: e442.
39. Baggaley RF, Garnett GP, Ferguson NM (2006) Modelling the impact of
antiretroviral use in resource-poor settings. PLoS Med 3: e124.
40. Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L (2007) Narrative review:
antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern
Med 146: 591–601.
41. Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley JW, et al. (2002)
Impact of highly active antiretroviral treatment on HIV seroincidence among
men who have sex with men: San Francisco. Am J Public Health 92: 388–394.
ART Beliefs & HIV Risk
PLoS ONE | www.plosone.org 9 March 2009 | Volume 4 | Issue 3 | e4573
